CN Patent
CN115947689B — 一种连续流微反应器合成利奥西呱中间体的方法
Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2025-08-29 · 1y expired
What this patent protects
本发明属于医药制备技术领域,具体涉及一种连续流微反应器合成利奥西呱中间体的方法,通过使用连续流工艺,较使用传统釜式微反应器的间歇式工艺,该方法具危险性小、易操作、对环境污染更小和稳定性高的特点。
USPTO Abstract
本发明属于医药制备技术领域,具体涉及一种连续流微反应器合成利奥西呱中间体的方法,通过使用连续流工艺,较使用传统釜式微反应器的间歇式工艺,该方法具危险性小、易操作、对环境污染更小和稳定性高的特点。
Drugs covered by this patent
- Adempas (RIOCIGUAT) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.